Qiagen N.V. financial data

Symbol
QGEN on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
Hulsterweg 82, Pl Venlo, Netherlands
State of incorporation
Netherlands
Fiscal year end
December 31
Former names
QIAGEN NV (to 2/14/2020)
Latest financial report
20-F - Q4 2023 - Mar 11, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 228M shares +0.21%
Common Stock, Value, Issued 2.7M USD 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 668M USD -8.57%
Accounts Receivable, after Allowance for Credit Loss, Current 382M USD +18%
Inventory, Net 398M USD +11.3%
Assets, Current 2.15B USD -10.3%
Property, Plant and Equipment, Net 765M USD +15.5%
Operating Lease, Right-of-Use Asset 105M USD +10.2%
Intangible Assets, Net (Excluding Goodwill) 527M USD -3.3%
Goodwill 2.48B USD +5.24%
Other Assets, Noncurrent 197M USD -2.93%
Assets 6.12B USD -2.74%
Accounts Payable, Current 84.2M USD -14.8%
Employee-related Liabilities, Current 81.4M USD -18.5%
Accrued Liabilities, Current 70M USD +12.1%
Contract with Customer, Liability, Current 66.4M USD -3.72%
Liabilities, Current 1.08B USD +10.8%
Operating Lease, Liability, Noncurrent 79.1M USD +10.7%
Other Liabilities, Noncurrent 207M USD -4.86%
Accumulated Other Comprehensive Income (Loss), Net of Tax -434M USD -7.36%
Retained Earnings (Accumulated Deficit) 2.46B USD +13.7%
Stockholders' Equity Attributable to Parent 3.81B USD +9.84%
Liabilities and Equity 6.12B USD -2.74%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 410M shares 0%
Common Stock, Shares, Issued 231M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 668M USD -8.57%
Deferred Tax Assets, Valuation Allowance 13.2M USD -37.9%
Deferred Tax Assets, Gross 141M USD -8.84%
Operating Lease, Liability 101M USD +8.23%
Lessee, Operating Lease, Liability, to be Paid 110M USD +8.88%
Property, Plant and Equipment, Gross 1.28B USD +10%
Operating Lease, Liability, Current 22.3M USD +0.22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.9M USD +11.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 25.1M USD +5.79%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +48.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.57M USD +17.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15M USD +10.7%
Deferred Tax Assets, Operating Loss Carryforwards 42.9M USD -19.2%
Unrecognized Tax Benefits 95.6M USD +20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.5M USD +23.2%
Additional Paid in Capital 1.92B USD +2.52%
Deferred Tax Assets, Net of Valuation Allowance 128M USD -4.21%